Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1) , 97-101
- https://doi.org/10.1053/sonc.2002.30235
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Statement on malignant mesothelioma in the United KingdomThorax, 2001
- Phase II Study of Vinorelbine in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2000
- Malignant mesothelioma: predictors of prognosis and clinical trialsThorax, 2000
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesotheliomaAnnals of Oncology, 1998
- A Review of Chemotherapy Trials for Malignant MesotheliomaChest, 1998
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.Journal of Clinical Oncology, 1994
- Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.Journal of Clinical Oncology, 1993
- Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistBritish Journal of Cancer, 1990